Skip to content

Combination of Psychosocial Intervention and Slow Prosecutions for the Treatment of Methamphetamine Abuse/Dependence

Combination of Psychosocial Intervention and Slow Prosecutions for the Treatment of Methamphetamine Abuse/Dependence

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01273701
Enrollment
60
Registered
2011-01-10
Start date
2011-01-31
Completion date
2012-12-31
Last updated
2011-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amphetamine Abuse, Amphetamine Dependence, Methamphetamine Abuse, Methamphetamine Dependence

Keywords

amphetamine, methamphetamine, psychosocial intervention, contingency management, slow prosecution, substance use disorder

Brief summary

The hospital where this study will be conducted is responsible for the one-year contingency management treatment for methamphetamine drug offenders referred from the Yunlin District Prosecutors Office. Completing the one-year treatment is prerequisite for offenders to get slow prosecutions. It is an open-label, parallel-group trial comparing the combination of psychosocial intervention and slow prosecutions with psychosocial intervention alone in treating subjects with methamphetamine dependence Study Hypothesis 1. Psychosocial interventions in combination with slow prosecutions is more effective than psychosocial interventions alone to achieve abstinence for subjects with methamphetamine abuse/dependance. 2. Inclusion of telephone reminding before each visit will enhance the retention rate and abstinence rate.

Interventions

BEHAVIORALPsychosocial intervention

The treatment is one-year long and composed of 3 stages of psychosocial intervention. Subjects of TSTSU arms receive urine methamphetamine examinations at each visit, while subjects in OPD arm being tested at first/last visits and during stage changes. -Stage 1, early intensive monitoring stage: The visit interval is 1 week. If the urine tests and self-report on methamphetamine use are negative for consecutive 4 visits, subjects can proceed to stage 2. (In OPD arm, the visit interval can be 2 weeks according to subjects' requirements.) -Sage 2, late intensive monitoring stage: The visit interval is 2 week. If the urine tests and self-reports are straightly negative for 4 visits, subjects can proceed to stage 3. Whenever recent methamphetamine is detected, subjects should move back to stage 1. -Stage 3, usual monitoring stage: The visit interval is 1 month until the end of treatment. Whenever recent methamphetamine is detected, subjects should move back to stage 1.

BEHAVIORALTelephone reminding

Subjects in TSTSU-T group will receive addition telephone reminding one day before each visit. Each call will be no longer than five minutes. On the telephone, brief motivation enhancement may be conducted.

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* DSM-IV-TR criteria for amphetamine/methamphetamine abuse or dependence * 18 - 65 years old * For TSTSU-N and TSTSU-T arms: methamphetamine offenders referred by the Yunlin District Prosecutors Office * For OPD arm: psychiatric outpatients referred from the psychiatry clinics in National Taiwan University Hospital, Yunlin Branch

Exclusion criteria

* Concurrent use of other illicit substances * Co-morbidity with major psychotic disorders (schizophrenia, schizoaffective disorder, other psychotic disorder), mental retardation, acute episodes of major depressive disorder or bipolar affective disorder) or serious personality disorders.

Design outcomes

Primary

MeasureTime frameDescription
Endpoint abstinence rateAt the end of one-year treatmentAccording to the urine amphetamine/methamphetamine screen after the one-year treatment, negative result suggests successful abstinence.

Secondary

MeasureTime frameDescription
Retention rateduring the whole one-year treatmentproportion of subjects who can complete the course of one-year treatment
Length of retentionduring the whole one-year treatmentthe averaged duration of attending treatment
The longest period of abstinenceduring the whole one-year treatmentthe longest period of time with successive negative results of urine amphetamine/methamphetamine tests or negative reports of recent methamphetamine use

Countries

Taiwan

Contacts

Primary ContactYi-Ting Lin, M.D.
p98421013@ntu.edut.tw+886-5-5323911

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026